Form 4: Guardant Health's Co-CEO Helmy Eltoukhy Reports Stock Transactions
SEC Form 4 Filing
Helmy Eltoukhy, Co-CEO of Guardant Health, reports the vesting of restricted stock units and associated tax withholding.
Summary
- On June 30, 2024, Helmy Eltoukhy, Co-Chief Executive Officer of Guardant Health, Inc., engaged in transactions involving the company's stock.
- Eltoukhy acquired 11,462 shares of common stock through the vesting of restricted stock units.
- Simultaneously, 5,809 shares were withheld by the company to cover tax obligations related to the vesting of these restricted stock units at a price of $28.88 per share.
- Following these transactions, Eltoukhy directly owns 2,298,614 shares of Guardant Health common stock and 22,923 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions, with neutral sentiment.
Positives
- The vesting of restricted stock units indicates a continued alignment of the Co-CEO's interests with those of the shareholders.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.
Stakeholder Impact
- The transactions provide transparency to shareholders regarding insider activity.
Key Dates
| Date | Description |
|---|---|
| 06/30/2024 | Date of stock transactions (vesting of restricted stock units and tax withholding). |
| 07/02/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.